Company Filing History:
1 out of 9 
1 out of 24 
1 out of 7 Years Active: 2018
Title: Gerhard Kelter: Innovator in HDAC6 Inhibitors
Introduction
Gerhard Kelter is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of HDAC6 inhibitors. His work focuses on small molecule compounds that have potential therapeutic applications in treating various diseases, including cancer.
Latest Patents
Kelter holds a patent for his invention titled "HDAC6 inhibitors and their uses." This patent describes small molecule compounds that act as HDAC inhibitors and outlines their use in treating diseases such as cancer. The invention also details methods for synthesizing these compounds and their application in treatment protocols.
Career Highlights
Throughout his career, Gerhard Kelter has worked with prestigious institutions, including the University of Regensburg and Friedrich Schiller University Jena. His research has contributed to advancements in the understanding and treatment of diseases through innovative chemical compounds.
Collaborations
Kelter has collaborated with notable colleagues, including Siavosh Mahboobi and Andreas Sellmer. These partnerships have fostered a collaborative environment that enhances research and development in the field of medicinal chemistry.
Conclusion
Gerhard Kelter's work in developing HDAC6 inhibitors showcases his commitment to advancing medical science. His innovative approach and collaboration with esteemed institutions and colleagues highlight the importance of teamwork in achieving breakthroughs in treatment options.